Published in J Natl Cancer Inst on February 04, 2004
Epidemiology of basal-like breast cancer. Breast Cancer Res Treat (2007) 7.08
Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA (2011) 4.25
Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res (2006) 3.62
How many etiological subtypes of breast cancer: two, three, four, or more? J Natl Cancer Inst (2014) 3.43
Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res (2007) 2.71
Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res (2008) 2.69
Age-related crossover in breast cancer incidence rates between black and white ethnic groups. J Natl Cancer Inst (2008) 2.64
Progesterone signalling in breast cancer: a neglected hormone coming into the limelight. Nat Rev Cancer (2013) 2.60
Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res (2009) 2.59
Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol (2008) 2.56
Genetic susceptibility to breast cancer. Mol Oncol (2010) 2.52
Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes. J Clin Oncol (2013) 2.46
Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proc Natl Acad Sci U S A (2010) 2.45
Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. Am J Epidemiol (2009) 2.14
Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Res Treat (2013) 2.07
Urban-rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt. Breast Cancer Res Treat (2009) 1.98
Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst (2011) 1.97
Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br J Cancer (2005) 1.94
Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res (2004) 1.85
Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst (2011) 1.75
Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.67
Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer. Breast Cancer Res Treat (2011) 1.58
Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2008) 1.53
Age at menopause: imputing age at menopause for women with a hysterectomy with application to risk of postmenopausal breast cancer. Ann Epidemiol (2011) 1.51
Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison. Breast Cancer Res (2006) 1.50
Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. Breast Cancer Res (2013) 1.49
Validation of a breast cancer risk prediction model developed for Black women. J Natl Cancer Inst (2013) 1.46
Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between black and white women? Cancer Causes Control (2013) 1.46
Alcohol and risk of breast cancer by histologic type and hormone receptor status in postmenopausal women: the NIH-AARP Diet and Health Study. Am J Epidemiol (2009) 1.42
Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports? Cancer Epidemiol Biomarkers Prev (2009) 1.41
Clinical characteristics of breast cancers in African-American women with benign breast disease: a comparison to the surveillance, epidemiology, and end results program. Breast J (2014) 1.39
Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Res (2012) 1.37
Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies. J Natl Cancer Inst (2012) 1.31
Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women. Cancer Res (2011) 1.28
Incorporating tumour pathology information into breast cancer risk prediction algorithms. Breast Cancer Res (2010) 1.28
Evolutionary foundations for cancer biology. Evol Appl (2013) 1.25
Mammographic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Res (2013) 1.23
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. Breast Cancer Res (2013) 1.23
Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study. Am J Epidemiol (2011) 1.22
Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors. Breast Cancer Res (2008) 1.20
Breast cancer risk prediction with heterogeneous risk profiles according to breast cancer tumor markers. Am J Epidemiol (2013) 1.19
A collaborative study of the etiology of breast cancer subtypes in African American women: the AMBER consortium. Cancer Causes Control (2013) 1.17
Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers. J Natl Cancer Inst (2011) 1.17
Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort. Breast Cancer Res (2010) 1.16
Fruit and vegetable intake in relation to risk of breast cancer in the Black Women's Health Study. Am J Epidemiol (2010) 1.16
Lobule type and subsequent breast cancer risk: results from the Nurses' Health Studies. Cancer (2009) 1.16
Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell (2013) 1.14
Risk prediction models with incomplete data with application to prediction of estrogen receptor-positive breast cancer: prospective data from the Nurses' Health Study. Breast Cancer Res (2008) 1.12
Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale. Carcinogenesis (2011) 1.10
Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010. BMC Cancer (2013) 1.09
Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivors. Cancer (2010) 1.08
Oral contraceptive use and estrogen/progesterone receptor-negative breast cancer among African American women. Cancer Epidemiol Biomarkers Prev (2010) 1.08
Is the biology of breast cancer changing? A study of hormone receptor status 1984-1986 and 1996-1997. Br J Cancer (2009) 1.07
UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res (2004) 1.05
Association of physical activity with hormone receptor status: the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev (2006) 1.04
Relative weight at age 12 and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.03
Breast cancer incidence and overdiagnosis in Catalonia (Spain). Breast Cancer Res (2010) 1.02
Risk factors for ductal and lobular breast cancer: results from the nurses' health study. Breast Cancer Res (2010) 1.02
Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors. Breast Cancer Res Treat (2011) 1.01
Breast cancer intrinsic subtype classification, clinical use and future trends. Am J Cancer Res (2015) 1.00
Familial relative risks for breast cancer by pathological subtype: a population-based cohort study. Breast Cancer Res (2010) 1.00
Population-based estimates of the relation between breast cancer risk, tumor subtype, and family history. Breast Cancer Res Treat (2008) 1.00
Active smoking, passive smoking, and breast cancer risk: findings from the Japan Collaborative Cohort Study for Evaluation of Cancer Risk. J Epidemiol (2008) 0.99
Mammographic screening and risk factors for breast cancer. Am J Epidemiol (2009) 0.99
Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion. Cancer (2010) 0.99
Body fat distribution and risk of premenopausal breast cancer in the Nurses' Health Study II. J Natl Cancer Inst (2010) 0.99
Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality. Annu Rev Public Health (2012) 0.98
Mammographic density and hormone receptor expression in breast cancer: the Multiethnic Cohort Study. Cancer Epidemiol (2011) 0.97
Progesterone and Overlooked Endocrine Pathways in Breast Cancer Pathogenesis. Endocrinology (2015) 0.96
Dietary fiber intake and risk of breast cancer in postmenopausal women: the National Institutes of Health-AARP Diet and Health Study. Am J Clin Nutr (2009) 0.96
Ethnic disparities in breast tumor phenotypic subtypes in Hispanic and non-Hispanic white women. J Womens Health (Larchmt) (2011) 0.96
Dietary fat and breast cancer risk in the Swedish women's lifestyle and health cohort. Br J Cancer (2007) 0.94
Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk. Breast Cancer Res Treat (2010) 0.93
Obesity and overfeeding affecting both tumor and systemic metabolism activates the progesterone receptor to contribute to postmenopausal breast cancer. Cancer Res (2012) 0.93
Body mass index and risk of second primary breast cancer: the WECARE Study. Breast Cancer Res Treat (2011) 0.93
Breast feeding, parity and breast cancer subtypes in a Spanish cohort. PLoS One (2012) 0.92
Migraine and subsequent risk of breast cancer: a prospective cohort study. Cancer Causes Control (2012) 0.91
Divergent estrogen receptor-positive and -negative breast cancer trends and etiologic heterogeneity in Denmark. Int J Cancer (2013) 0.91
Validation of Rosner-Colditz breast cancer incidence model using an independent data set, the California Teachers Study. Breast Cancer Res Treat (2013) 0.90
Factors to consider in the association between soy isoflavone intake and breast cancer risk. J Epidemiol (2010) 0.90
Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors. Int J Cancer (2014) 0.90
Obesity/weight gain and breast cancer risk: findings from the Japan collaborative cohort study for the evaluation of cancer risk. J Epidemiol (2013) 0.89
Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: are there differences before and after age 40? Breast Cancer Res Treat (2013) 0.89
Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry. Br J Cancer (2014) 0.89
Building pathway clusters from Random Forests classification using class votes. BMC Bioinformatics (2008) 0.89
Does change in the neighborhood environment prevent obesity in older women? Soc Sci Med (2013) 0.89
Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women. Clin Breast Cancer (2014) 0.89
Family history and breast cancer hormone receptor status in a Spanish cohort. PLoS One (2012) 0.88
Differences in estrogen receptor subtype according to family history of breast cancer among Hispanic, but not non-Hispanic White women. Cancer Epidemiol Biomarkers Prev (2008) 0.88
Oncoprotein HCCR-1 expression in breast cancer is well correlated with known breast cancer prognostic factors including the HER2 overexpression, p53 mutation, and ER/PR status. BMC Cancer (2009) 0.88
Body size throughout adult life influences postmenopausal breast cancer risk among hispanic women: the breast cancer health disparities study. Cancer Epidemiol Biomarkers Prev (2014) 0.87
The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis. Breast Cancer Res (2010) 0.87
Body size, modifying factors, and postmenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area Breast Cancer Study. Springerplus (2013) 0.86
What can be learnt from models of incidence rates? Breast Cancer Res (2006) 0.86
HER-2 positive breast cancer: decreasing proportion but stable incidence in Finnish population from 1982 to 2005. Breast Cancer Res (2009) 0.86
Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies. Int J Cancer (2016) 0.86
Estrogen Receptor Status and the Future Burden of Invasive and In Situ Breast Cancers in the United States. J Natl Cancer Inst (2015) 0.85
Use of modified Magee equations and histologic criteria to predict the Oncotype DX recurrence score. Mod Pathol (2015) 0.85
Dietary patterns and risk of breast cancer. Br J Cancer (2010) 0.85
Prognostic value of morphology and hormone receptor status in breast cancer - a population-based study. Br J Cancer (2004) 0.85
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96
Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94
Physical activity and survival after breast cancer diagnosis. JAMA (2005) 8.60
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39
The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer (2005) 8.19
Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension (2007) 6.99
Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA (2005) 6.89
Insulin-like growth factors and neoplasia. Nat Rev Cancer (2004) 6.29
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22
Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86
Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79
Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol (2006) 5.22
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol (2011) 4.74
A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet (2008) 4.57
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Aspirin intake and survival after breast cancer. J Clin Oncol (2010) 4.50
Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA (2011) 4.25
Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol (2005) 4.04
High school dietary dairy intake and teenage acne. J Am Acad Dermatol (2005) 4.00
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Smoking and smoking cessation in relation to mortality in women. JAMA (2008) 3.68
Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst (2006) 3.65
Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst (2004) 3.43
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37
Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst (2004) 3.28
Adult weight change and risk of postmenopausal breast cancer. JAMA (2006) 3.11
Social networks, social support, and survival after breast cancer diagnosis. J Clin Oncol (2006) 3.09
Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat Genet (2009) 3.06
Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol (2008) 3.04
The role of prolactin in mammary carcinoma. Endocr Rev (2003) 2.95
Low-carbohydrate diets and all-cause and cause-specific mortality: two cohort studies. Ann Intern Med (2010) 2.95
Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst (2003) 2.92
Active and passive smoking in breast cancer: prospective results from the Nurses' Health Study. Epidemiology (2002) 2.86
A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol (2007) 2.80
Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev (2004) 2.75
Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol (2004) 2.72
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72
Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis. J Natl Cancer Inst (2008) 2.69
Serum lipids, lipid-lowering drugs, and the risk of breast cancer. Arch Intern Med (2005) 2.66
Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum (2004) 2.62
Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr (2007) 2.56
Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation (2003) 2.52
A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol (2007) 2.50
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45
Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 2.37
Prospective evaluation of analgesic use and risk of renal cell cancer. Arch Intern Med (2011) 2.34
Milk consumption and acne in teenaged boys. J Am Acad Dermatol (2008) 2.33
Night work and risk of breast cancer. Epidemiology (2006) 2.30
Dietary fat types and 4-year cognitive change in community-dwelling older women. Ann Neurol (2012) 2.29
Night shift work and the risk of endometrial cancer. Cancer Res (2007) 2.28
Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res (2006) 2.27
A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 2.23
White rice, brown rice, and risk of type 2 diabetes in US men and women. Arch Intern Med (2010) 2.22
Relation of food cost to healthfulness of diet among US women. Am J Clin Nutr (2010) 2.19
Nonnarcotic analgesic use and the risk of hypertension in US women. Hypertension (2002) 2.16
Intake of dairy products, calcium, and vitamin d and risk of breast cancer. J Natl Cancer Inst (2002) 2.16
Anthropometric measures and their relation to incident primary open-angle glaucoma. Ophthalmology (2010) 2.15
A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev (2005) 2.15
Physical activity and risk of breast cancer among postmenopausal women. Arch Intern Med (2010) 2.15
Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk? J Clin Oncol (2006) 2.14
Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev (2006) 2.14
Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet (2012) 2.12
Challenges to the measurement of estradiol: an endocrine society position statement. J Clin Endocrinol Metab (2013) 2.11
Dietary patterns and survival after breast cancer diagnosis. J Clin Oncol (2005) 2.11
Androgen receptor expression and breast cancer survival in postmenopausal women. Clin Cancer Res (2011) 2.11
Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev (2004) 2.10
Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst (2011) 2.09
Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev (2010) 2.09
Fish consumption and risk of stroke in men. JAMA (2002) 2.08
Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Res Treat (2013) 2.07
Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab (2007) 2.07
Teenage acne and cancer risk in US women: A prospective cohort study. Cancer (2015) 2.05
A prospective study of breast size and premenopausal breast cancer incidence. Int J Cancer (2006) 2.04
High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proc Natl Acad Sci U S A (2011) 2.03
Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care (2003) 2.02
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst (2007) 2.01
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model. Endocr Relat Cancer (2007) 2.01
Age at menarche and risk of type 2 diabetes: results from 2 large prospective cohort studies. Am J Epidemiol (2009) 1.99
Diet quality is associated with the risk of estrogen receptor-negative breast cancer in postmenopausal women. J Nutr (2006) 1.98
Obesity treatment for socioeconomically disadvantaged patients in primary care practice. Arch Intern Med (2012) 1.98
Cigarette smoking and the incidence of breast cancer. Arch Intern Med (2011) 1.97
Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.95
Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Cancer Epidemiol Biomarkers Prev (2007) 1.95